Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, noviembre 21
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Moderna Inc
MRNA
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$195.00
-4.33
-2.17%
al cierre: Nov 20, 4:00 PM EST
$199.30
4.30
2.21%
After hour: 7:56 PM EST
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Moderna Financials
Moderna (MRNA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Moderna Analyst Day: Details Strategic Shift Toward Oncology and Enhanced Production Capabilities
Moderna raises its 2026 revenue forecast to 15%-25% and accelerates oncology investments, expanding its mRNA platform into new therapies.
Vandana Singh
Moderna Stuns Wall Street With Surprise Profit, Raises Outlook
Moderna (MRNA) jumps as Q3 earnings swing to a surprise profit of $0.38/share on strong global vaccine sales and cost cuts.
Vandana Singh
PRO
Moderna Raises FY2026 Sales Guidance from $2.138B to $2.236B-$2.430B vs $2.102B Est
Moderna (NASDAQ:MRNA) raises FY2026 sales outlook from $2.138 billion to $2.236 billion-$2.430 billion vs $2.102 billion estimate.
Benzinga Newsdesk
PRO
Moderna Q3 EPS $0.38 Beats $(1.26) Estimate, Sales $1.313B Beat $885.051M Estimate
Moderna (NASDAQ:MRNA) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $(1.26) by 130.16 percent. This is a 174.51 percent increase over losses of $(0.51) per share from the
Benzinga Newsdesk
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Moderna reports Q3 earnings Friday, with analysts expecting a $1.25 loss per share and $890M revenue; shares fell 6.6% after vaccine approvals.
Avi Kapoor
Stock Market: Will S&P 500 Open Up or Down Today?
Will the S&P 500 open higher? Polymarket odds hit 62% as Wall Street eyes jobs data and a tech rebound.
Rishabh Mishra